TABLE 1.

Patient clinical and demographic data

Age/gender	Handedness	Age of epilepsy onset (year)	Seizure types and frequency (per month)	Postop outcome (Engel class.)	MRI and pathological diagnosis	Epilepsy syndrome	VIQ	PIQ	Verbal recall	Figure recall	Right HV (cm3)	Left HV (cm3)	Total intracranial volume (cm3)	Hippocampal volume ratio (%)	Language dominance
25/F	Right	17	CPS 8 SGTC 0.5	IA	Left HS	Left TLE	82	80	46	60	2.729	1.351	168.53	50	Left
37/M	Left	1	SPS 12 CPS 4	IB	Left HS	Left TLE	94	93	23	49	3.3	1.88	175	57	Left
33/M	Right	1	SPS 4 CPS 4	IA	Left HS	Left TLE	86	88	46	91	2.83	2.02	NM	71	Left
32/F	Right	22	SPS 30 CPS 5 SGTC 0.25	NA	Left HS	Left TLE	88	111	27	40	2.359	1.789	152.9	76	Left
37/F	Right	18	CPS 10	IA	Left HS	Left TLE	105	110	50	66	2.912	1.602	143.5	55	Left
28/M	Right	3	CPS 1	IA	Left HS	Left TLE	76	81	18	10	3.077	1.417	171.24	46	Left
34/M	Right	21	CPS 5	NA	Left HS	Left TLE	67	76	3	8	2.235	1.896	172.2	85	Left
25/M	Right	5	CPS 3	NA	Right HS	Right TLE	101	90	50	59	1.84	2.35	NM	78	Left
47/M	Right	13	CPS 1	IB	Right HS	Right TLE	73	86	36	18	1.038	2.769	145.92	37	Left
44/F	Right	14	CPS 4	IA	Right HS	Right TLE	95	104	64	80	2.606	3.034	154.9	86	Left
46/F	Right	8	CPS 5	IA	Right HS	Right TLE	88	84	60	13	1.756	2.695	147	65	Left
32/F	Right	19	CPS 2	IIIA	Right HS	Right TLE	87	110	80	66	2.299	2.562	139.55	90	Left
29/M	Right	9	CPS 30 SGTC 4	NA	Right HS	Right TLE	93	114	88	84	2.273	2.978	162.86	76	Left
41/F	Right	14	CPS 4	IA	Right HS	Right TLE	90	88	75	47	1.628	2.302	150.8	71	Left

M, male; F, female; CPS, complex partial seizure; SGTC, secondary generalized tonic–clonic seizure; NA, not applicable; HS, hippocampal sclerosis; EEG, electroencephalogram; TLE, temporal lobe epilepsy; VIQ, verbal intelligence quotient; PIQ, performance intelligence quotient; HV, hippocampal volume; AED, antiepileptic drug; TPR, topiramate; LTG, lamotrigine; VPA, sodium valproate; CBZ, carbamazepine; LVT, levetiracetam; PMD, primidone; CLB, clobazam; OXC, oxcarbazepine; GBP, gabapentin; PHT, phenytoin; TGB, tiagabine.